Ampio Pharmaceuticals, Inc. (AMPE)

0.1831 0.00 (0.00%) USD  |  OTCM  |  Jun 16, 16:00
More

Ampio Pharmaceuticals SG&A Expense (Quarterly)

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AMPE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2023 0.973M
September 30, 2023 1.071M
June 30, 2023 1.216M
March 31, 2023 3.819M
December 31, 2022 1.962M
September 30, 2022 2.975M
June 30, 2022 3.245M
March 31, 2022 3.283M
December 31, 2021 4.491M
September 30, 2021 1.257M
June 30, 2021 1.40M
March 31, 2021 1.523M
December 31, 2020 1.766M
September 30, 2020 1.647M
June 30, 2020 1.482M
March 31, 2020 1.767M
December 31, 2019 1.653M
September 30, 2019 1.745M
June 30, 2019 1.445M
March 31, 2019 1.112M
December 31, 2018 1.052M
September 30, 2018 0.7561M
June 30, 2018 1.015M
March 31, 2018 1.530M
December 31, 2017 1.368M
Date Value
September 30, 2017 1.074M
June 30, 2017 1.340M
March 31, 2017 1.363M
December 31, 2016 1.307M
September 30, 2016 1.556M
June 30, 2016 1.563M
March 31, 2016 2.111M
December 31, 2015 4.756M
September 30, 2015 3.411M
June 30, 2015 4.007M
March 31, 2015 2.961M
December 31, 2014 2.963M
September 30, 2014 3.299M
June 30, 2014 3.328M
March 31, 2014 2.073M
December 31, 2013 2.101M
September 30, 2013 1.152M
June 30, 2013 1.220M
March 31, 2013 1.312M
December 31, 2012 1.436M
September 30, 2012 0.6779M
June 30, 2012 0.7272M
March 31, 2012 1.536M
December 31, 2011 0.9607M
September 30, 2011 1.372M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 73.66M
Corcept Therapeutics, Inc. 145.36M
Assertio Holdings, Inc. 11.14M
Veru, Inc. 4.073M
Johnson & Johnson 6.034B